Fed. Circ. Told Acting USPTO Chief Can't Implement Arthrex
Two patent owners told the Federal Circuit on Wednesday that there were "significant questions" about the legality of the U.S. Patent and Trademark Office's plan for its temporary leader to review...To view the full article, register now.
Already a subscriber? Click here to view full article